Dr. Hagop M. Kantarjian on the Generic Formulation of Imatinib
Автор: Targeted Oncology
Загружено: 2012-12-03
Просмотров: 1680
Описание:
Hagop M. Kantarjian, MD, Department Chair, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, describes the effect of a generic formulation of imatinib.
Kantarjian says that 80,000 CML patients receive TKIs today and a generic formulation of imatinib could reduce the cost of TKIs to 10% of its current price. However, the oncology community is looking for a significant difference in 5- to 10-year survival in erlotinib and nilotinib compared to generic imatinib.
For more resources visit: http://targetedhc.com/
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: